Case Report
Year 2021,
Volume: 13 Issue: 1, 36 - 38, 30.04.2021
Abstract
Hipoglisemi birçok nedene bağlı gelişebilmektedir ve bu nedenler arasında maligniteler de yer almaktadır. Sıklıkla adacık hücre malignitelerinde gözlenmekle birlikte hepatoselüler karsinom gibi malignitelerde de hipoglisemi gözlenebilmektedir. Dirençli hipoglisemi ile başvuran olgumuzda öncelikle endokrinolojik sebepler düşünülmüş, ancak etiyoloji tespit edilememiştir. Muayenesinde splenomegali tespit edilen hastanın batın ultrasonografisi ve dinamik magnetik rezonans görüntülemesinde multifokal hepatoselüler karsinom saptanmıştır. Hipoglisemi ile prezente olan hepatoselüler karsinomlu orta yaş erkek hasta sunulmuştur.
References
- 1) 1) Kahn CR. Theriddle of tumour hypoglycaemia revisited. J Clin Endocrinol Metab 1980;9:335-60.
- 2) Luo JC, Hwang SJ, Wu JC, Lai CR, Li CP, Chang FY, et al. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology. 2002; 49: 1315‑1319.
- 3) Saigal S, Nandeesh HP, Malhotra V and Sarin SK: A case of hepatocellular carcinoma associated with trouble some hypoglycemia: management bycyto reductionusing percutaneous ethanol injection. Am J Gastroenterol. 1998;93:1380‑1381.
- 4) Tangkijvanich P, Thong-Ngam D, Kullavanijaya P, Suwangool P. Fibrolamellar hepatocellularcarcinoma in a Thaiman who presented with hypoglycemia: case reportand review of literature. J MedAssocThai. 2000; 83:809.
- 5) T.W. Bodnar,M. J. Acevedo, and M. Pietropaolo, “Management of non-islet-cell tumor hypoglycemia: a clinicalreview,” Journal of Clinical Endocrinology and Metabolism. 2014;99(3):713–722.
- 6) Marks V &Teale JD Tumour sproducing hypoglycaemia. Endocrine-Related Cancer. 1998;5: 111–129.
- 7) S. Nikeghbalian, A. Bananzadeh, and H. Yarmohammadi,“Hypoglycemia, the first presenting sign of hepatocellular carcinoma,” Saudi Medical Journal. 2006;27(3):387-388.
- 8) R. T. Yeung, “Hypoglycaemia in hepatocellularcarcinoma: a review,” Hong Kong MedicalJournal. 1997;3:297–301.
- 9) Kalebi AY, Hale MJ, Wong ML, Hoffman T andMurray J: Surgically cured hypoglycemia secondary to pleuralsolitary fibrous tumour: case reportand update review on the Doege‑Potter syndrome. J CardiothoracSurg. 2009;4:45.
- 10) Le Roith D: Tumor‑induced hypoglycemia. N Engl J Med.1999;341: 757‑758.
- 11) Hoff AO and Vassilopoulou‑Sellin R: The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer 1998;82: 1585‑1592.
Year 2021,
Volume: 13 Issue: 1, 36 - 38, 30.04.2021
Abstract
References
- 1) 1) Kahn CR. Theriddle of tumour hypoglycaemia revisited. J Clin Endocrinol Metab 1980;9:335-60.
- 2) Luo JC, Hwang SJ, Wu JC, Lai CR, Li CP, Chang FY, et al. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology. 2002; 49: 1315‑1319.
- 3) Saigal S, Nandeesh HP, Malhotra V and Sarin SK: A case of hepatocellular carcinoma associated with trouble some hypoglycemia: management bycyto reductionusing percutaneous ethanol injection. Am J Gastroenterol. 1998;93:1380‑1381.
- 4) Tangkijvanich P, Thong-Ngam D, Kullavanijaya P, Suwangool P. Fibrolamellar hepatocellularcarcinoma in a Thaiman who presented with hypoglycemia: case reportand review of literature. J MedAssocThai. 2000; 83:809.
- 5) T.W. Bodnar,M. J. Acevedo, and M. Pietropaolo, “Management of non-islet-cell tumor hypoglycemia: a clinicalreview,” Journal of Clinical Endocrinology and Metabolism. 2014;99(3):713–722.
- 6) Marks V &Teale JD Tumour sproducing hypoglycaemia. Endocrine-Related Cancer. 1998;5: 111–129.
- 7) S. Nikeghbalian, A. Bananzadeh, and H. Yarmohammadi,“Hypoglycemia, the first presenting sign of hepatocellular carcinoma,” Saudi Medical Journal. 2006;27(3):387-388.
- 8) R. T. Yeung, “Hypoglycaemia in hepatocellularcarcinoma: a review,” Hong Kong MedicalJournal. 1997;3:297–301.
- 9) Kalebi AY, Hale MJ, Wong ML, Hoffman T andMurray J: Surgically cured hypoglycemia secondary to pleuralsolitary fibrous tumour: case reportand update review on the Doege‑Potter syndrome. J CardiothoracSurg. 2009;4:45.
- 10) Le Roith D: Tumor‑induced hypoglycemia. N Engl J Med.1999;341: 757‑758.
- 11) Hoff AO and Vassilopoulou‑Sellin R: The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer 1998;82: 1585‑1592.
There are 11 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Clinical Sciences |
| Journal Section | Case Report |
| Authors | |
| Publication Date | April 30, 2021 |
| Submission Date | December 23, 2020 |
| Published in Issue | Year 2021 Volume: 13 Issue: 1 |
